期刊文献+

肝素抗凝治疗时对PT-INR的影响与分析 被引量:1

ANALYSIS AND EFFECT ON PT-INR INFLUENCED BY HEPARIN ANTI-COAGULANT THERAPY
下载PDF
导出
摘要 [目的]了解肝素治疗时对PT-INR的影响。[方法]对144例肝素抗凝患者的APTT及PT-INR进行了直线相关与回归分析。[结果]PT-INR与APTT呈正相关,相关系数r=0.659,P﹤0.001;其直线回归方程为INR=0.974+0.002325APTT。[结论]肝素治疗对PT-INR有影响。 [Objective] To study the effect on PT-INR influenced by heparin anti-coagulant therapy. [Methods] linear correlation and regression analyses were performed to analyze the APTT and PT-INR of 144 patients with heparin antl-coagulant therapy. [ Results] PT-INR and APTT were significantly positive correlation, and the coefficient correlation was 0.659 (P 〈 0.001 ); The linear regression equation was INR =0.974+0.002325APTT. [ Conclusion] Heparin anti-coagulant therapy cart influence the PT-INR.
出处 《现代预防医学》 CAS 北大核心 2008年第2期368-369,共2页 Modern Preventive Medicine
关键词 抗凝 肝素 部份活化凝血活酶时间APTT 国际标准化比率PT-INR Anti-coagulation: Heparin Activated partial thromboptastin time APTT International normalized ratio PT-INR
  • 相关文献

参考文献1

二级参考文献14

  • 1Manson L, Weitz IJ, Podor JT,et al. The variable anticoagulant response to unfractionated heparin in vivo reflects binding to plasma proteins rather than clearance. J Lab Clin Med, 1997, 130(6):649-655.
  • 2Hyers TM, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease. Chest, 2001, 119: 176-193.
  • 3Brown G, Dodek P. An evaluation of empiric vs.nomogram-based dosing of haparin in an intensive care unit. Crit Care Med, 1997, 25(9):1534-1538.
  • 4Geogory MS. Weight-based heparin dosing: Maybe it is just a matter of time . Crit Care Med ,1997, 25(9):1451-1452.
  • 5Rosborough KT. Monitoring unfractionated heparin therapy with antifactor Ⅹa activity results in fewer monitoring tests and dosage changes than monitoring with the activated partial thromboplastin time. Pharmacoeconomics ,1999,19(6):761-766.
  • 6Hirsh J, Warkentin ET, Raschke R, et al. Heparin and low-molecular-weight heparin: mechanisms of action, pharmcokinetics, dosing considerations, monitoring, efficacy, and safety. Chest, 1998 ,114(5): 489-503.
  • 7Kitchen S, Preston FE. The therapeutic range for heparin therapy: relationship between six activated partial thromboplastin time reagents and two heparin assays. Thrombosis and Haemostasis, 1996,75(5):734-739.
  • 8Kearon C, Johnson M, Moffat K, et al. Effect of warfarin on activated partial thromboplastin time in patients receiving heparin. Arch Intern Med, 1998, 158(25):1140-1143.
  • 9Smythe AM, Koerber MJ, Westley JS, et al. Different Heparin Lots--Does It Matter? Arch Pathol Lab Med, 2001, 125:1458-1462.
  • 10Granger BC, Hirsh J, Califf MR, et al. Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: result from the GUSTO-1 trail. Circulation,1996,93 (5):870-877.

共引文献7

同被引文献4

  • 1Tang XF, Liu JJ, Wu Y J, et al. balloon catheter injury-induced Effect of hirulog-like peptide on neointimal formation in fenoral arteries of minipigs and relationship with inflammatory mediators [J]. JVascRes, 2009, 47 (3): 262-269.
  • 2Hammerstingl C, Schmitz A, Fimmers R, et al. Bridging of chronic oral anticoagulation with enoxaparin in patients with atrial fibrillation: results from the prospective brave registry [ J]. Car- diovasc Ther, 2009, 27 (4) : 230 -238.
  • 3叶祖峰,陈莉.STA compact全自动血凝仪的使用体会[J].吉林医学,2008,29(15):1304-1305. 被引量:3
  • 4罗华,梁瑛.肝素治疗肺血栓栓塞症达标剂量与达标时间初步研究[J].心肺血管病杂志,2009,28(3):178-182. 被引量:6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部